4
Changes in Ownership
AIM ImmunoTech Inc. Filed Acc 0001613377-18-000009
Options or other derivatives
- Exec. Vice Chairman/CEO/Pres. acquired 250,000 shares (grant or award)
- Exec. Vice Chairman/CEO/Pres. acquired 300,000 shares (other)
From the SEC's structured data for this filing
Trades in this filing
EQUELS THOMAS K. · Exec. Vice Chairman/CEO/Pres.
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-05-16 | Grant or award : show line 1 in the form Options to buy Common Stock | +250,000 | 250,000 | D |
| 2018-05-16 | Other acquisition : show line 2 in the form Options to buy Common Stock | +300,000 | 795,833 | D |
Loading xslF345X03/primary_doc.xml…